Buy Day today: Good (67) Broad market participation · no major macro event

Corcept Therapeutics Incorporated (CORT)

Healthcare Biotechnology

112.80 $

-1.5% vs. previous close

Closing price · As of: 3. Aug 2026

Corcept Therapeutics Incorporated (CORT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 889 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow

Annual Quarterly

All figures in millions of USD.

Balance Sheet CORT
Tick rows to compare them in a chart (up to 4)	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	594	622	656	715	784	841	846	802	824	837	815	889
Current Assets	432	459	503	561	467	472	439	443	541	485	426	440
Cash	112	136	150	129	137	128	90	103	125	120	109	111
Cash & Short-Term Investments	355	368	411	473	380	383	323	342	422	372	338	308
Receivables	50	57	64	56	63	58	84	69	74	60	39	77
Inventory	7.5	7.7	7.2	8.4	8.1	12	14	12	12	13	13	13
Property, Plant & Equipment	0.5	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	132	115	108	118	145	161	163	166	192	189	177	183
Current Liabilities	122	105	97	101	126	141	143	145	172	166	149	154
Short-Term Debt	0.2	0.2	0.1	0.0	0.4	0.8	1.0	1.0	1.1	1.1	1.6	1.9
Accounts Payable	17	17	13	19	19	15	28	24	34	40	33	15
Shareholders' Equity	462	507	548	596	639	680	683	636	632	648	638	706
Retained Earnings	371	403	430	466	513	544	564	599	619	643	612	655
Shares Outstanding	111	111	110	111	114	118	120	120	119	120	104	118

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Cookie settings